XML 132 R26.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Quarterly Financial Information (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Financial Information (Unaudited) | Quarterly Financial Information (Unaudited)
In millions, except per share amounts | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter |  | Year
2019: |  |  |  |  |  |  |  |  |
Total revenues | $ | 61,646 |  |  | $ | 63,431 |  |  | $ | 64,810 |  |  | $ | 66,889 |  |  | $ | 256,776 |
Operating income | 2,690 |  |  | 3,332 |  |  | 2,928 |  |  | 3,037 |  |  | 11,987 |
Income from continuing operations | 1,427 |  |  | 1,931 |  |  | 1,529 |  |  | 1,744 |  |  | 6,631 |
Net income attributable to CVS Health | 1,421 |  |  | 1,936 |  |  | 1,530 |  |  | 1,747 |  |  | 6,634 |
Per common share data: |  |  |  |  |  |  |  |  |
Basic earnings per common share: |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health | $ | 1.09 |  |  | $ | 1.49 |  |  | $ | 1.17 |  |  | $ | 1.34 |  |  | $ | 5.10 |
Income from discontinued operations attributable to CVS Health | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net income attributable to CVS Health | $ | 1.09 |  |  | $ | 1.49 |  |  | $ | 1.17 |  |  | $ | 1.34 |  |  | $ | 5.10 |
Diluted earnings per common share: |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health | $ | 1.09 |  |  | $ | 1.49 |  |  | $ | 1.17 |  |  | $ | 1.33 |  |  | $ | 5.08 |
Income from discontinued operations attributable to CVS Health | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net income attributable to CVS Health | $ | 1.09 |  |  | $ | 1.49 |  |  | $ | 1.17 |  |  | $ | 1.33 |  |  | $ | 5.08 |
Dividends per common share | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 2.00 |
In millions, except per share amounts | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter |  | Year
2018: |  |  |  |  |  |  |  |  |
Total revenues | $ | 45,743 |  |  | $ | 46,922 |  |  | $ | 47,490 |  |  | $ | 54,424 |  |  | $ | 194,579 |
Operating income (loss) | 1,996 |  |  | (1,373 | ) |  | 2,574 |  |  | 824 |  |  | 4,021 |
Income (loss) from continuing operations | 998 |  |  | (2,562 | ) |  | 1,390 |  |  | (422 | ) |  | (596 | )
Net income (loss) attributable to CVS Health | 998 |  |  | (2,563 | ) |  | 1,390 |  |  | (419 | ) |  | (594 | )
Per common share data: |  |  |  |  |  |  |  |  |
Basic earnings (loss) per common share: |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Income (loss) from discontinued operations attributable to CVS Health | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net income (loss) attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Diluted earnings (loss) per common share: |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Income (loss) from discontinued operations attributable to CVS Health | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net income (loss) attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Dividends per common share | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 2.00 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration